CUOMO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 6.411
EU - Europa 5.899
AS - Asia 3.599
SA - Sud America 816
Continente sconosciuto - Info sul continente non disponibili 365
AF - Africa 249
OC - Oceania 48
Totale 17.387
Nazione #
US - Stati Uniti d'America 6.204
IT - Italia 2.053
SG - Singapore 1.186
RU - Federazione Russa 1.056
CN - Cina 993
GB - Regno Unito 971
BR - Brasile 639
IE - Irlanda 548
VN - Vietnam 374
HK - Hong Kong 277
FR - Francia 260
SE - Svezia 244
DE - Germania 196
KR - Corea 188
IN - India 153
UA - Ucraina 134
CA - Canada 115
BD - Bangladesh 106
FI - Finlandia 94
ZA - Sudafrica 94
AR - Argentina 73
NL - Olanda 71
TR - Turchia 65
MX - Messico 52
ES - Italia 49
KE - Kenya 47
PL - Polonia 42
AU - Australia 39
JP - Giappone 36
IQ - Iraq 31
AT - Austria 30
NG - Nigeria 25
EC - Ecuador 24
CI - Costa d'Avorio 22
CH - Svizzera 20
ID - Indonesia 20
PE - Perù 20
VE - Venezuela 19
GR - Grecia 18
PH - Filippine 17
MY - Malesia 16
PK - Pakistan 16
SA - Arabia Saudita 16
CO - Colombia 15
MA - Marocco 15
UZ - Uzbekistan 12
CZ - Repubblica Ceca 11
EG - Egitto 11
HU - Ungheria 11
CL - Cile 10
DK - Danimarca 10
IR - Iran 10
PT - Portogallo 10
TH - Thailandia 10
CR - Costa Rica 9
DZ - Algeria 8
NZ - Nuova Zelanda 8
PY - Paraguay 8
RO - Romania 8
TW - Taiwan 8
IM - Isola di Man 7
JO - Giordania 7
OM - Oman 7
RS - Serbia 7
UG - Uganda 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
BG - Bulgaria 6
IL - Israele 6
LT - Lituania 6
NO - Norvegia 6
NP - Nepal 6
SK - Slovacchia (Repubblica Slovacca) 6
TT - Trinidad e Tobago 6
KZ - Kazakistan 5
PR - Porto Rico 5
TN - Tunisia 5
AL - Albania 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
JM - Giamaica 4
KG - Kirghizistan 4
SV - El Salvador 4
UY - Uruguay 4
BF - Burkina Faso 3
BO - Bolivia 3
EE - Estonia 3
KW - Kuwait 3
MD - Moldavia 3
PS - Palestinian Territory 3
SI - Slovenia 3
BH - Bahrain 2
CY - Cipro 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
LB - Libano 2
MU - Mauritius 2
Totale 17.000
Città #
Southend 780
Dallas 749
Singapore 560
Dublin 538
Ashburn 496
San Jose 449
Milan 410
Santa Clara 392
Fairfield 376
Moscow 334
Houston 272
Hefei 268
Hong Kong 255
Beijing 250
Council Bluffs 229
Siena 227
Chandler 199
Florence 186
Rome 185
Seoul 177
Woodbridge 166
Wilmington 143
Seattle 126
Cambridge 119
Los Angeles 111
Jacksonville 108
Ho Chi Minh City 103
New York 102
The Dalles 97
Princeton 80
Lauterbourg 76
Johannesburg 75
Dong Ket 71
Hanoi 71
São Paulo 67
Ann Arbor 63
Helsinki 57
Columbus 50
Munich 48
Bengaluru 42
Buffalo 42
Redondo Beach 42
Boardman 41
Orem 38
Naples 37
Chicago 35
Nairobi 34
Nanjing 34
Rio de Janeiro 33
San Diego 33
Phoenix 31
Figino 30
San Mateo 30
Turin 30
Bologna 28
Washington 28
London 27
San Francisco 27
Brooklyn 26
Montreal 26
Warsaw 26
Chennai 25
Málaga 24
Nuremberg 24
Tokyo 24
Abuja 23
Brescia 23
Abidjan 22
Toronto 22
Sanliurfa 21
Cinisello Balsamo 20
Lappeenranta 20
Manchester 19
Prato 19
Amsterdam 18
Da Nang 18
Mumbai 18
Palermo 18
Boston 16
Frankfurt am Main 16
Lima 16
Mexico City 16
Miami 16
Paris 16
Sydney 16
Trento 16
Vienna 16
Atlanta 15
Campinas 15
Dhaka 15
Shanghai 15
Tianjin 15
Belo Horizonte 14
Cape Town 14
Denver 14
Livorno 14
Lucca 14
Stockholm 14
Norwalk 13
Salt Lake City 13
Totale 10.472
Nome #
Trazodone: a multifunctional antidepressant. Evaluation of its properties and real-world use 585
Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder 537
"TREATMENT-RESISTANT DEPRESSION" AND USE OF INTRAVENOUS KETAMINE AND INTRANASAL ES-KETAMINE 454
Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice 425
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder 381
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice 316
Antidepressant and pro-motivational effects of repeated lamotrigine treatment in a rat model of depressive symptoms 303
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review 291
Drug safety evaluation of aripiprazole in bipolar disorder 286
Feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity 258
Advances in treatment for postpartum major depressive disorder 248
Therapeutic Potential of Saffron Extract in Mild Depression: A Study of Its Role on Anhedonia in Rats and Humans 239
Prevalence and correlates of Vitamin D deficiency in a sample of 290 inpatients with mental illness 233
Effectiveness of light therapy as adjunctive treatment in bipolar depression: A pilot study 233
Treatment persistence in patients with schizophrenia treated with lurasidone in Italian clinical practice 228
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients 228
Prevalence, chronicity, burden and borders of bipolar disorder 221
Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice 221
A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope? 217
Does higher severity really correlate with a worse quality of life in obsessive-compulsive disorder? A meta-regression 217
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 214
A new approach for seasonal pattern: is it related to bipolarity dimension? Findings from an Italian multicenter study 214
S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): A clinician-oriented systematic review 213
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 212
Internet use by older adults with bipolar disorder: international survey results 210
Perfenazina, amitriptilina e perfenazina-amitriptilina: Ruolo nella pratica clinica [Perphenazine, amitriptyline and perphenazine-amitriptyline: Role in clinical practice] 209
Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: Pharmacology and clinical practice 206
Psychological interventions for post-traumatic stress disorder in women survivors of intimate partner violence: A systematic review and meta-analysis 205
Neuroticism and conscientiousness moderate the effect of oral medication beliefs on adherence of people with mental illness during the pandemic 203
The neural bases of social cognition in major depressive disorder: a review [La cognizione sociale nel disturbo depressivo maggiore: Una rassegna sulle basi neurali] 203
Exploring treatment strategies for mood stabilization in patients with major depressive disorder and mixed features 202
On the centrality of mixed features in mood disorders: Listening to Kraepelin and Weygandt and moving forward 202
Mood spectrum symptoms during a major depressive episode: Differences between 145 patients with bipolar disorder and 155 patients with major depressive disorder. Arguments for a dimensional approach 202
Effectiveness and Tolerability of Supratherapeutic Dosing of Vortioxetine in Patients With Treatment-Resistant Depression 198
Mental health in Italy after two years of COVID-19 from the perspective of 1281 Italian physicians: looking back to plan forward 195
Accuracy of self-assessment of real-life functioning in schizophrenia 193
Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting 193
Biomarkers, Inflammation, and Bipolar Disorder: Association Between the Improvement of Bipolar Disorder Severity and the Improvement in C-Reactive Protein Levels After 7 Days of Inpatient Treatment 186
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 185
Efficacy of topiramate in treating obsessive compulsive disorder: A systematic review and meta-analysis 182
Is intravenous valproate more efficacious than oral valproate for inpatients with bipolar I disorder with a manic or depressive episode and concomitant symptoms of opposite polarity? 182
Symptom modulation and tolerability of intravenous ketamine in treatment-resistant bipolar depression: A retrospective study 180
The impact of COVID-19 pandemic in patients with a diagnosis of Oral Lichen Planus: Pain perception and psychological profile analysis 178
Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations 168
Which mixed depression model? A comparison between DSM-5-defined mixed features and Koukopoulos' criteria 166
Treating major depressive disorder with mixed features 165
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia 163
Lamotrigine in bipolar disorder: preventing depression to treat the disease 161
COVID-19 Diary from a Psychiatry Department in Italy 159
La responsabilità dello psichiatra [Duties and liabilities for psychiatrists] 158
Five-year follow-up of first-episode depression treated with psychodynamic psychotherapy or antidepressants 157
Lurasidone in adolescents and adults with schizophrenia: from clinical trials to real-world clinical practice 155
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings 154
Perspectives on the impact of vortioxetine on the treatment armamentarium of major depressive disorder 152
Worldwide prevalence of obsessive-compulsive symptoms during the COVID-19 pandemic: A systematic review and meta-analysis 148
Association between polarity of first episode and solar insolation in bipolar I disorder 147
Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel 147
Practical guidance for prescribing trazodone extended-release in major depression 143
QTc interval diurnal variations in patients treated with psychotropic medications: implications for the evaluation of drug induced QTc changes 140
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 140
Insights into the Incidence, Course, and Management of Lithium-Induced Hypothyroidism in Real-World Psychiatric Practice in Italy 137
Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patients 137
Unraveling the Boundaries, Overlaps, and Connections between Schizophrenia and Obsessive–Compulsive Disorder (OCD) 135
Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder 134
null 134
Principi di farmacodinamica e farmacocinetica nello switch tra antipsicotici: focus su cariprazina 134
Effectiveness of Intramuscular Chlorpromazine for Rapid Treatment of Psychomotor Agitation: A Naturalistic, Retrospective, and Observational Study 133
Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis 130
Medico-legal implications of mobbing: a case law [Riflessioni medico-legali su un caso giudiziario di mobbing] 129
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 127
Personalized treatment of depression phenotypes: Role of trazodone in depression with insomnia 126
Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder 122
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 121
Erratum: Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations (BMC Medicine (2020) 18 (215) DOI: 10.1186/s12916-020-01685-9) 120
Vulnerabilities in Mental Health due to Covid-19 Pandemic: The Response of the Italian Physicians 117
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 117
Impact of menstrual cycle events on bipolar disorder course: a narrative review of current evidence 113
Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release 113
Investigating the Relationship between Autistic Traits, Ruminative Thinking, and Suicidality in a Clinical Sample of Subjects with Bipolar Disorder and Borderline Personality Disorder 113
Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis 112
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 112
Personalized medicine with extended-release trazodone and/or once-a-day trazodone: From research trials to clinical practice 112
Drug-drug interactions between COVID-19 therapeutics and psychotropic medications 112
Treatment persistence with aripiprazole once monthly: a 4-year follow-up 111
Autistic symptoms in unaffected first-degree relatives of people with schizophrenia: results from the Italian Network for Research on Psychoses multicenter study 110
Individualized strategies for depression: narrative review of clinical profiles responsive to vortioxetine 110
Prolonged grief disorder in psychiatric patients: Assessing the PG-13-R scale and clinical implications 109
Rethinking the role of trazodone in the different depressive dimensions 103
Practical prescribing with COVID-19 medications and psychotropics: a guide to pharmacokinetic interactions 99
Pocket Guide to Practical Psychopharmacology : Lithium and Anticonvulsants in Psychiatric Practice 95
Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features 94
Liquid antipsychotics in the management of psychomotor agitation: a focus on promazine 92
Employment and Social Security/Insurance among patients affected by mental disorders in Italy: A descriptive multi-center study 89
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the "real-life" 86
Rehabilitation in adults with complex psychosis: a clinician-oriented narrative review of multidimensional approaches to functional recovery 53
Valproate-enhanced Protocols for alcohol withdrawal syndrome: a brief review and retrospective study of efficacy and the ability to reduce benzodiazepine use 28
Inflammatory and Immune Biomarkers in Mood Disorders: From Mechanistic Pathways to Clinical Translation 21
Long-Acting Injectable Antipsychotics in Adolescents: From Current Evidence and Gaps to Clinical Practice 18
Efficacy and Tolerability of Bupropion in Major Depressive Disorder with Comorbid Anxiety Symptoms: A Systematic Review 18
Totale 17.387
Categoria #
all - tutte 54.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.259


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022588 0 0 0 77 42 40 64 46 83 48 58 130
2022/2023963 56 61 135 88 63 156 31 148 97 44 40 44
2023/20241.385 77 37 96 90 51 287 343 42 18 99 113 132
2024/20253.367 112 148 229 330 369 285 143 142 260 256 350 743
2025/20266.824 553 904 654 787 1.053 295 701 280 253 399 344 601
2026/20271.273 356 298 468 151 0 0 0 0 0 0 0 0
Totale 17.387